DEFA1 and cancer: Conversely, DEFA1 can inhibit angiogenesis by impairing endothelial cell proliferation and migration [46], and high concentrations of DEFA1-3 exhibit cytotoxicity against cancer cell lines [47], the effect of which was first documented in early studies showing that human and rabbit granulocyte defensins mediate in vitro tumor cell cytolysis.